17th ANNUAL EARLY HEARING DETECTION & INTERVENTION MEETING
March 18-20, 2018 • Denver, CO
| Hearing Targeted CMV
Hearing Targeted CMV
Congenital cytomegalovirus (cCMV) infection is being increasingly recognized as a major cause of congenital hearing loss. It is estimated that 10% to 20% of congenital sensorineural hearing loss is caused by cCMV (Hicks 1993; Park 2014; Goderis 2014)). Knowledge of the etiology of hearing loss at the time of diagnosis can assist in developing treatment plans for the affected child. While several states currently have legislation regarding screening and/or perinatal education about CMV screening, New Jersey currently has no such legislation. Hearing screens were conducted in many New Jersey hospitals before universal newborn hearing screening legislation was passed. Similarly, some New Jersey hospitals are beginning to implement CMV screening, with initial efforts beginning in 2017.
The University Medical Center of Princeton at Plainsboro (UMCPP) and AtlantiCare Regional Medical Center are affiliated with the Children’s Hospital of Philadelphia through the CHOP Newborn Care Network (CNBC). In conjunction with the CHOP department of Otolaryngology, CNBC is recommending that affiliated hospitals perform CMV testing prior to hospital discharge on infants who refer (fail) on in-hospital testing, for both unilateral or bilateral fails.
There are several methods in which CMV testing can be performed:
• Urine culture
o Gold Standard
o May be difficult to obtain
o Poor for universal detection
o Long turn-around time
• Urine PCR
o Short turn-around time
o May be difficult to obtain
• Saliva PCR (both liquid and dried)
o Good sensitivity (99.9%)
o Good specificity (97%)
o Easy to obtain
o May require urine culture for confirmation of positive results
Turn -around time for PCR test is the same for the two sample types (urine or swab) – at least 1 day and maximum of 3 days. In our units, the price is the same for all sample types: $61.00.
Our poster will present summary statistics on cCMV screens performed and results. Barriers and successes encountered during implementation will also be discussed.
- Identify mulitple methods for CMV Testing
- Describe barriers in obtaining samples for CMV testing in Newborns
- Describe procedures to implement hospital-based CMV testing
Presentation:
15805_7826KarenBaker.pdf
Handouts:
15805_7826KarenBaker_1.docx
15805_7826KarenBaker_x.doc
Transcripts:
CART transcripts are NOT YET available, but will be posted shortly after the conference
Presenters/Authors
Karen Baker
(), The University Medical Center of Princeton at Plainsboro, kbaker@princetonhcs.org;
Karen Baker is the Operations Coordinator for the CHOP Newborn and Pediatric Care Network and the Administrator of the Newborn Hearing Program at the University Medical Center of Princeton at Plainsboro. She has been the coordinator for the department of Neonatology for over 10 years during which time she was involved in the process of expanding the level of care in the Neonatal Intensive Care Unit.
As the Recording Secretary for the NJ EHDI QI Stakeholder Committee and member of the NJ EHDI Timely Follow up Learning Community, Karen has effectively managed the hearing program including follow up for at risk infants born at UMCPP. She has been instrumental in improving the hospital’s Hearing Screening policies and procedures and key to improving education for the staff and parents.
ASHA DISCLOSURE:
Financial -
No relevant financial relationship exist.
Nonfinancial -
No relevant nonfinancial relationship exist.
Barbara Moyer
(), AtlantiCare Regional Medical Center, Barbara.Moyer@atlanticare.org;
Barbara Moyer, a native of South Jersey, has worked in two local hospitals for 30+ years, mainly in the mother-baby units. She is currently an Administrative Associate at AtlantiCare Regional Medical Center. During this past year, she has been an active team member of the New Jersey NICHQ/IHSIS committee. A self-proclaimed data geek, Barb has worked with the Electronic Birth Certificate database from 1995-2011 collecting and compiling data. Then newborn hearing became a part of that database. In 2001 Barb's second grandson was born with hearing loss and malformation of his right ear which deepened her involvement in the hearing program and follow-up of the newborns. Barb has been actively involved in improving the hospitals procedures, educating parents and improving hearing follow-up. She works with the local audiology center to coordinate services.
ASHA DISCLOSURE:
Financial -
No relevant financial relationship exist.
Nonfinancial -
No relevant nonfinancial relationship exist.
Kathryn Aveni
(), New Jersey Department of Health, Kathryn.Aveni@doh.nj.gov;
Kathryn Aveni received her Master's in Public Health from Columbia University and BS in Nursing from the University of Virginia. She is a Research Scientist and Data System Coordinator for Special Child Health and Early Intervention Services at the New Jersey Department of Health where she has worked since 2002. She also serves as a Regional EHDI Technical Assistant Network Consultant for the National Center for Hearing Assessment and Management.
ASHA DISCLOSURE:
Financial -
No relevant financial relationship exist.
Nonfinancial -
No relevant nonfinancial relationship exist.
Linda Biando
(), NJ DHSS - EHDI Program, linda.biando@doh.nj.gov;
Linda Biando received her MSN in Perinatology from the University of Pennsylvania and BSN in Nursing from the University of Massachusetts. She is a Public Health Consultant with the New Jersey Department of Health in the Early Hearing Detection and Intervention Program. Ms. Biando was the New Jersey Team Lead for the most recent NICHQ/IHSIS grant during 2012-2013. She facilitates follow-up with hospitals, the medical home and others in her work with the New Jersey EHDI program.
ASHA DISCLOSURE:
Financial -
No relevant financial relationship exist.
Nonfinancial -
No relevant nonfinancial relationship exist.